3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vomiting
14
Nausea
13
Ovarian Neoplasms
4
Neoplasms
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Breast Neoplasms
4
Sezary Syndrome
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Testicular Neoplasms
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Neuroblastoma
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Neutrophilic, Chronic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Interventions
blinatumomab
6
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
ponatinib
2
fludarabine
2
denileukin diftitox
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Everolimus
2
Etoposide
2
Doxorubicin
2
Darbepoetin alfa
2
Cytarabine
2
Busulfan
2
Brentuximab Vedotin
2
Antilymphocyte Serum
2
Alemtuzumab
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoproliferative Disorders
×
Aprepitant
×
Clear all
No trials found.